Cuur Diagnostics

Vaginal Microbiota Panel

VAGINAL MICROBIOTA PANEL

CUUR DiagnosticsTM is dedicated to maintaining the largest data set of infectious disease targets available in the world.

The implications of diagnosing women’s health infections extend far beyond that of each patient – it can affect their partners and even their children. Particularly when it comes to infectious disease, it’s essential to get fast, reliable and actionable results.

The newly discovered female urinary microbiota has the potential to deepen our understanding of urinary tract health and disease, including common lower urinary tract conditions such as urinary incontinence and urinary tract infection. The female urinary microbiota possesses characteristics that differ between women affected by urgency urinary incontinence and matched, unaffected controls.

Traditional culture-based or microscopy-based methods for analysis of the vaginal microbiota can be time-consuming, overly subjective and inaccurate due to lack of sensitivity and specificity. CUUR Diagnostics’ molecular technology solution can detect microbes that are slow growing, difficult to grow or that fail to grow under traditional methods providing clear, precise and actionable categorization of microorganisms involved.

Helix DNA
TARGETS

BACTERIA VAGINOSIS 
Bacteria VaginosisAtopobium vaginae
Bacteria VaginosisBacteroides fragilis
Bacteria VaginosisBVAB2
Bacteria VaginosisGardnerella vaginalis
Bacteria VaginosisPrevotella bivia
Bacteria VaginosisMegasphaera 1*
Bacteria VaginosisMegasphaera 2*
Bacteria VaginosisMobiluncus curtisii
Bacteria VaginosisMobiluncus mulieris
Bacteria VaginosisMycoplasma hominis
Bacteria VaginosisUreaplasma urealyticum**

NORMAL FLORA (NON-PATHOGENIC) 
Normal Flora (Non-Pathogenic)Lactobacillus crispatus
Normal Flora (Non-Pathogenic)Lactobacillus gasseri
Normal Flora (Non-Pathogenic)Lactobacillus iners
Normal Flora (Non-Pathogenic)Lactobacillus jensenii

Vaginal Microbiota Aerpboc Vaginitis 
Aerpboc VaginitisStaphylococcus aureus
Aerpboc VaginitisStreptococcus agalactiae (group B)
Aerpboc VaginitisEnterococcus faecalis
Aerpboc VaginitisEscherichia coli

Vaginal Candidiasis 
Vaginal CandidiasisCandida albicans
Vaginal CandidiasisCandida dubliniensis
Vaginal CandidiasisCandida glabrata
Vaginal CandidiasisCandida krusei
Vaginal CandidiasisCandida lusitaniae
Vaginal CandidiasisCandida parapsilosis
Vaginal CandidiasisCandida tropicalis

Vaginal Group-B Strep 
Vaginal Group-B StrepStreptococcus agalactiae

Sexually Transmitted Infectious (STI) Pathogens 
Sexually Transmitted Infectious (STI) PathogensChlamydia trachomatis
Sexually Transmitted Infectious (STI) PathogensHaemophilus ducreyi
Sexually Transmitted Infectious (STI) PathogensHerpes simplex 1
Sexually Transmitted Infectious (STI) PathogensHerpes simplex 2
Sexually Transmitted Infectious (STI) PathogensMycoplasma genitalium
Sexually Transmitted Infectious (STI) PathogensNeisseria gonorrhoeae
Sexually Transmitted Infectious (STI) PathogensTreponema pallidum
Sexually Transmitted Infectious (STI) PathogensTrichomonas vaginalis

ICD-10 CODES

ICD-10 CodesDescription
N71.0Acute inflammatory disease of uterus
N71.1Chronic inflammatory disease of uterus
N71.9Inflammatory disease of uterus, unspecified
N72Inflammatory disease of cervix uteri
N73.9Female pelvic inflammatory disease, unspecified
N74Female pelvic inflammatory disorders in diseases classified elsewhere
N76.0Acute vaginitis
N76.1Subacute and chronic vaginitis
N76.2Acute vulvitis
N76.3Subacute and chronic vulvitis
N76.4Abscess of vulva
N76.8Other specified inflammation of vagina and vulva

Infectious Disease Care

D I A G N O S T I C S

STATISTICALLY SPEAKING
  • Vulvovaginal candidiasis (VVC) affects about 75% of reproductive-aged women at least once during their lives, with about 5% of them suffering of recurrences.
  • Chlamydia trachomatis (CT) represents the most common bacterial STI worldwide, and new infections probably exceed 131 million per year